Intravitreal (IVT) Injectable Market Size, Share and Growth Forecast for 2025 - 2032

Table of Content

1. Executive Summary
   1. Global Intravitreal (IVT) Injectable Market Snapshot, 2025 and 2032
   2. Market Opportunity Assessment, 2025 – 2032, US$ Mn
   3. Key Market Trends
   4. Future Market Projections
   5. Premium Market Insights
   6. Industry Developments and Key Market Events
   7. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definition
   2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
   3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
   4. COVID-19 Impact Analysis
   5. Forecast Factors – Relevance and Impact
3. Value Added Insights
   1. Regulatory Landscape
   2. Product Adoption Analysis
   3. Value Chain Analysis
   4. Key Deals and Mergers
   5. PESTLE Analysis
   6. Porter’s Five Force Analysis
4. Global Intravitreal (IVT) Injectable Market Outlook:
   1. Key Highlights
      1. Market Size (US$ Mn) and Y-o-Y Growth
      2. Absolute $ Opportunity
   2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2019-2024
      2. Current Market Size (US$ Mn) Analysis and Forecast, 2025–2032
   3. Global Intravitreal (IVT) Injectable Market Outlook: Drug Class
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Drug Class, 2019 – 2024
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025 – 2032
         1. Anti-VEGF
         2. Corticosteroids
         3. Antibiotics
         4. Antivirals
         5. Antifungals
      4. Market Attractiveness Analysis: Drug Class
   4. Global Intravitreal (IVT) Injectable Market Outlook: Indication
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Indication, 2019 – 2024
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 – 2032
         1. Macular Degeneration
         2. Diabetic Retinopathy
         3. Retinal Vein Occlusion
         4. Endophthalmitis
         5. Others
      4. Market Attractiveness Analysis: Indication
5. Global Intravitreal (IVT) Injectable Market Outlook: Region
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Region, 2019 – 2024
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025 – 2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
   4. Market Attractiveness Analysis: Region
6. North America Intravitreal (IVT) Injectable Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 – 2024
      1. By Country
      2. By Drug Class
      3. By Indication
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 – 2032
      1. U.S.
      2. Canada
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025 – 2032
      1. Anti-VEGF
      2. Corticosteroids
      3. Antibiotics
      4. Antivirals
      5. Antifungals
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 – 2032
      1. Macular Degeneration
      2. Diabetic Retinopathy
      3. Retinal Vein Occlusion
      4. Endophthalmitis
      5. Others
   6. Market Attractiveness Analysis
7. Europe Intravitreal (IVT) Injectable Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 – 2024
      1. By Country
      2. By Drug Class
      3. By Indication
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 – 2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025 – 2032
      1. Anti-VEGF
      2. Corticosteroids
      3. Antibiotics
      4. Antivirals
      5. Antifungals
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 – 2032
      1. Macular Degeneration
      2. Diabetic Retinopathy
      3. Retinal Vein Occlusion
      4. Endophthalmitis
      5. Others
   6. Market Attractiveness Analysis
8. East Asia Intravitreal (IVT) Injectable Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 – 2024
      1. By Country
      2. By Drug Class
      3. By Indication
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 – 2032
      1. China
      2. Japan
      3. South Korea
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025 – 2032
      1. Anti-VEGF
      2. Corticosteroids
      3. Antibiotics
      4. Antivirals
      5. Antifungals
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 – 2032
      1. Macular Degeneration
      2. Diabetic Retinopathy
      3. Retinal Vein Occlusion
      4. Endophthalmitis
      5. Others
   6. Market Attractiveness Analysis
9. South Asia & Oceania Intravitreal (IVT) Injectable Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 – 2024
      1. By Country
      2. By Drug Class
      3. By Indication
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 – 2032
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025 – 2032
      1. Anti-VEGF
      2. Corticosteroids
      3. Antibiotics
      4. Antivirals
      5. Antifungals
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 – 2032
      1. Macular Degeneration
      2. Diabetic Retinopathy
      3. Retinal Vein Occlusion
      4. Endophthalmitis
      5. Others
   6. Market Attractiveness Analysis
10. Latin America Intravitreal (IVT) Injectable Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 – 2024
       1. By Country
       2. By Drug Class
       3. By Indication
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 – 2032
       1. Brazil
       2. Mexico
       3. Rest of Latin America
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025 – 2032
       1. Anti-VEGF
       2. Corticosteroids
       3. Antibiotics
       4. Antivirals
       5. Antifungals
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 – 2032
       1. Macular Degeneration
       2. Diabetic Retinopathy
       3. Retinal Vein Occlusion
       4. Endophthalmitis
       5. Others
    6. Market Attractiveness Analysis
11. Middle East & Africa Intravitreal (IVT) Injectable Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 – 2024
       1. By Country
       2. By Drug Class
       3. By Indication
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 – 2032
       1. GCC Countries
       2. Egypt
       3. South Africa
       4. Northern Africa
       5. Rest of Middle East & Africa
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025 – 2032
       1. Anti-VEGF
       2. Corticosteroids
       3. Antibiotics
       4. Antivirals
       5. Antifungals
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 – 2032
       1. Macular Degeneration
       2. Diabetic Retinopathy
       3. Retinal Vein Occlusion
       4. Endophthalmitis
       5. Others
    6. Market Attractiveness Analysis
12. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
       1. Competition Intensity Mapping By Market
       2. Competition Dashboard
    3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
       1. Regeneron Pharmaceuticals, Inc.
          1. Overview
          2. Segments and Products
          3. Key Financials
          4. Market Developments
          5. Market Strategy
       2. Bausch & Lomb
       3. Novartis AG
       4. Allergan
       5. Alimera Sciences
       6. ThromboGenics, Inc.
       7. Bristol-Myers Squibb Company
       8. Roche Holding AG (Genentech)
       9. Ocular Therapeutix, Inc.
       10. Clearside Biomedical, Inc.
       11. Biogen Inc.
       12. Bayer Yakuhin, Ltd (Bayer AG)
13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations